期刊文献+

参脂灵合血脂康治疗糖尿病合并高脂血症动物实验研究

Animal experiment study on the treatment of diabetes and hyperlipidemiain rats with shenzhiling and Xuezhikang
下载PDF
导出
摘要 探讨参脂灵与血脂康合用对实验性糖尿病高脂血症大鼠血糖、血脂、血流变的影响。结果参脂灵与血脂康合用能够明显降低糖尿病高脂血症大鼠血糖、胆固醇、甘油三酯及全血比粘度 (高切 )和血浆比粘度 ,其降低甘油三酯作用优于单纯血脂康、参脂灵。 Effects of Shenzhiling and Xuezhikang on experimental diabetes and hyperlipemia in rats was studied.The results showed that shenzhiling and Xuezhikang cound remarkably lower blood sugar,TC and TG.It also could deereased 7β,7P in rats.It was found that the effect of shenzhiling and Xuezhikang was obviously lower than that of xuezhikang or Shenzhiling.
出处 《辽宁中医杂志》 CAS 2004年第11期965-966,共2页 Liaoning Journal of Traditional Chinese Medicine
基金 上海市宝山区科委科研课题 ( 0 3 -A -3 0 )
关键词 糖尿病合并高脂血症 参脂灵 血脂康 动物实验 diabetes and hyperlipemia shenzhiling Xuezhikang animal experiment
  • 相关文献

参考文献1

  • 1[2]Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based prospective studies[J ]. J Cardiovasc Rick, 1996, 3: 213.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部